Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2007
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132146A1 Dhfr enzyme inhibitors
11/22/2007WO2007112399A3 Tetrahydro-pyrazolo[3,4-c]pyridine cannabinoid modulators
11/22/2007WO2007081909A3 Forms of dolasetron mesylate and processes for their preparation
11/22/2007WO2007081540A3 Tylophorine analogs as antitumor agents
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007WO2006104915A3 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
11/22/2007WO2006099268A3 Cgrp receptor antagonists
11/22/2007WO2006091394A3 Substituted imidazoquinolines and imidazonaphthyridines
11/22/2007WO2006076726A9 Synthesis of sodium narcistatin and related compounds
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270581 Storage stability; mixture of tetrahydrobiopterin and excipient
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270441 Combination
11/22/2007US20070270429 Function Inhibitor of Effector Cell
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/22/2007DE102006021733A1 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung 3 Tetrazolylindazole and 3-Tetrazolylpyrazolopyridine and their use
11/22/2007CA2652866A1 Therapeutic compounds
11/22/2007CA2651654A1 Substituted azaspiro derivatives
11/22/2007CA2649102A1 Compounds and compositions as protein kinase inhibitors
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856117A1 Indolopyridines, benzofuranopyridines and benzothienopyridines
11/21/2007EP1856116A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856079A1 Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1855664A2 Mitotic kinesin inhibitors
11/21/2007EP1697378B1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1474135B1 Indole, azaindole and related heterocyclic pyrrolidine derivatives
11/21/2007EP1320571B1 3-spiro-cyanin fluorochromes and their use in bioassays
11/21/2007CN101076532A Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
11/21/2007CN101076530A Method for producing quaterrylene-3,4:13,14-tetracarboxy diimides by direct synthesis
11/21/2007CN101076333A Pyrazolo-heteroaryl compounds useful to treat TNF-alpha and IL-1 mediated diseases
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN101074229A 7-azaindirubin and 7-azaisoindigo derivative, its production and pharmaceutical use
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN100349894C Naphthyridine derivatives and their use as fungicides
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349517C Fused heterocyclic sulfonylurea compound, herbicide containing the same and method of controlling weed with the same
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297790 Anhydrous mirtazapine crystals and process for preparing the same
11/20/2007US7297705 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/15/2007WO2007130860A2 Constrained compounds as cgrp-receptor antagonists
11/15/2007WO2007130468A2 Pyrido [2, 3-b] pyrazine and [1, 8] -naphthyridine derivatives as alk and c-met inhibitors
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129020A1 Pyrimidine derivatives useful as dhfr inhibitors
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128568A1 Bicyclic derivatives as cetp inhibitors
11/15/2007WO2007128460A1 Substituted 3 -amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
11/15/2007WO2007128454A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof
11/15/2007WO2007090579A3 Substituted quinolones iii
11/15/2007WO2007090141A3 Pyrrolo [2, 3, b] pyridine derivatives useful as raf kinase inhibitors
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007067416A3 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007WO2007000043A3 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors
11/15/2007WO2004032856A3 Compounds
11/15/2007US20070265451 Process for the preparation of oxazolidinones and method of use thereof
11/15/2007US20070265348 Therapeutic guanidines
11/15/2007US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007US20070265298 Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives for the Treatment of Obesity
11/15/2007US20070265295 1-Heterocyclyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265271 (8-Methyl-3,8-diaza-bicyclo[3.2.1]oct-3-yl)-[5-(4-nitro-phenyl)-furan-2-yl]-methanone; cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; nervous system diseases; inflammation, pain; drug addiction
11/15/2007US20070265250 Imidazole compounds
11/15/2007US20070265249 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction
11/15/2007US20070265240 Sequence Selective Pyrrole and Imidazole Polyamide Metallocomplexes
11/15/2007US20070265193 Tetraazabenzo[e]azulene derivatives and analogs thereof
11/15/2007US20070264600 Heterocyclic Colorants Based on Diazabenzoisoindoles
11/15/2007DE102007030076A1 Verfahren zum Trocknen von Druckfarbe auf einem Bedruckstoff Method of drying printing ink on a printing material
11/15/2007DE10148172B4 Fluoreszierende Naphthalin-1,4,5,8-tetracarbonsäurebisimide mit elektronenschiebendem Substituenten am Kern Fluorescent naphthalene-1,4,5,8-tetracarboxylic with elektronenschiebendem substituents on the core
11/15/2007CA2651556A1 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
11/15/2007CA2650954A1 Bicyclic derivatives as cetp inhibitors
11/15/2007CA2646128A1 Pyrido [2, 3-b] pyrazine and [1, 8] -naphthyridine derivatives as alk and c-met inhibitors
11/14/2007EP1853610A1 N-phenyl benzamide derivatives as sirtuin modulators
11/14/2007EP1853606A1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/14/2007EP1853605A2 Integrin targeted synthetic ligands for diagnostic and therapeutic applications
11/14/2007EP1853604A2 Chemical compounds
11/14/2007EP1853603A1 Peptidomimetic compounds and preparation of biologically active derivatives
11/14/2007EP1853602A1 Chemical compounds
11/14/2007EP1853601A1 Non steroidal glucocorticoid receptor modulators
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1761529B1 Pyrrolopyridine derivatives and their use as crth2 antagonists
11/14/2007EP1716147B1 Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1539756B1 Imidazopyridines as cyclin dependent kinase inhibitors
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1483262B1 Coumarines useful as biomarkers
11/14/2007EP1409480B1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
11/14/2007EP1104765B2 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof
11/14/2007CN101072780A Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 646